Likely active: new deal Nov 2024 Verified 5 Nov 2026
Versant Venture Capital
San Francisco biotech venture firm founded in 1999 with $5.5B under management, launching and funding biotechnology companies globally through in-house discovery engines and academic partnerships.
- Type
- VC firm
- Location
- San Francisco, California, United States
- Stages
- Seed
- Backs
- Biotech and pharma, Medtech and digital health
- Sectors
- Biotech
- Fund size / AUM
- $600.4M Versant Venture Capital IX (Form D offering, 2022); $3.88B gross private fund assets (Form ADV; private funds: 28, of which venture capital: 28)
- Latest fund or filing
- 7 Apr 2023
- Portfolio mix
- Biotech and pharma 78%; Medtech and digital health 17%; B2B software 4% (n=23, 2019 to 2024)
- Website
- www.versantventures.com
Contacts on file
For Versant Venture Capital, the paid file holds: 8 named decision-makers with roles; LinkedIn page.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Sources
- www.sec.gov/Archives/edgar/data/1947466/000194746623000001/
- adviserinfo.sec.gov/firm/summary/161130
- www.versantventures.com/
- www.sec.gov/Archives/edgar/data/1947469/000194746923000001/
- www.versantventures.com/team
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 19 lists
Medtech investors in the San Francisco Bay Area (76)Biotech investors in the San Francisco Bay Area (88)Medtech investors in California (92)Biotech investors in California (108)Seed biotech investors in the US (159)Seed medtech investors in the US (205)Seed medtech investors (278)Biotech venture capital firms in the US (297)Seed biotech investors (300)Seed investors in the San Francisco Bay Area (324)Medtech venture capital firms in the US (350)Seed investors in California (415)Medtech investors (457)Biotech investors (484)Venture capital firms in the San Francisco Bay Area (768)Venture capital firms in California (1,038)Seed investors in the US (1,043)Seed investors (1,892)Venture capital firms in the US (2,975)